Cabozantinib With Topotecan-Cyclophosphamide

Clinical trial NCT04661852 · COMPLETED

Trial details

NCT number: NCT04661852
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Ewing Sarcoma Refractory Ewing Sarcoma Relapsed Osteosarcoma Refractory Osteosarcoma

Start date: 2020-12-23
Primary completion: 2022-10-24
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.